Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374563 | Bioorganic & Medicinal Chemistry Letters | 2010 | 5 Pages |
Abstract
A series of IAP antagonists based on thiazole or benzothiazole amide isosteres was designed and synthesized. These compounds were tested for binding to the XIAP-BIR3 and ML-IAP BIR using a fluorescence polarization assay. The most potent of these compounds, 19a and 33b, were found to have Ki’s of 20–30 nM against ML-IAP and 50–60 nM against XIAP-BIR3.
Graphical abstractThe co-crystal structure of peptide 1 with an ML-IAP BIR construct was used to guide amide bond replacement with either a thiazole or benzothiazole, leading to potent IAP antagonists such as 11e and 26d.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Frederick Cohen, Michael F.T. Koehler, Philippe Bergeron, Linda O. Elliott, John A. Flygare, Matthew C. Franklin, Lewis Gazzard, Stephen F. Keteltas, Kevin Lau, Cuong Q. Ly, Vickie Tsui, Wayne J. Fairbrother,